Latest market price
28.41
-0.76-2.61%
IMVTQT25Immunovant, Inc.·NASDAQ
28.41-2.61%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 20264Statement of changes in beneficial ownership
Oct 23, 20264Statement of changes in beneficial ownership
Oct 09, 20264Statement of changes in beneficial ownership
Oct 09, 20264Statement of changes in beneficial ownership
Oct 09, 20264Statement of changes in beneficial ownership
Oct 05, 20264Statement of changes in beneficial ownership
Sep 25, 20264Statement of changes in beneficial ownership
Sep 03, 20268-KCurrent report
Aug 28, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 22, 2026ARSAnnual report to shareholders
Jul 22, 2026DEF 14ADefinitive proxy statement
Jul 22, 2026DEFA14AAdditional proxy soliciting materials
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership